Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,173.0
19.4 (0.62%)

 

  • STI Straits Times Index
    3,173.0
    19.4 (0.62%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,578.3
    2.7 (0.17%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    28,637.5
    219.5 (0.77%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,441.3
    -5.6 (-0.16%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    29,331.4
    518.7 (1.80%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,970.2
    -5.7 (-0.09%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,538.5M
  • Value: 1,410.6M
  • Rise: 183
  • Fall: 118
  • Unch: 470

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Shen Yao0.008+0.002
VCPlus0.033+0.004
YZJ Shipbldg SGD1.520+0.060
Jiutian Chemical0.099+0.003
Oceanus^0.037-
Sembcorp Marine0.200+0.002
MM2 Asia0.063+0.001
Leader Env0.130-0.010
The Place Hldg0.131+0.005
Singtel2.450+0.040

World Indices

World Indices
Name Last Change
Nasdaq 13,582.4 -51.1
HSI 28,637.5 +219.5
HSCEI 10,756.4 +34.5
Jakarta 5,970.2 -5.7
Nikkei 225 29,331.4 +518.7
SSE Comp 3,441.3 -5.6
Shanghai A 3,607.0 -5.8
Shanghai B 248.6 -0.7
KOSPI 3,178.7 +31.4

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

ENOCHIAN BIOSCIENCES INC ENOCHIAN BIOSCIENCES
Updated on 05 May 2021 (End of trading day)
Last (USD): 3.850 Change: +0.320 High: 3.935 Remarks: -
Change (%): +9.07 Low: 3.620
Open 3.690 Yesterday's Close 3.5300000000000002
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 242,083 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.23911 Trailing EPS (USD) e -0.22918 NAV (USD) b 3.3917
PE a - Trailing PE f - Price / NAV b 1.1351
Dividend (USD) d - Cash In Hand (USD) g 0.0717 Issued & Paid-up Shares c 47,745,800
Dividend Yield (%) d - Price / Cash In Hand g 53.696 Treasury Shares h -
Market Cap (M) 183.821 Enterprise Value (M) 188.480
Piotroski F Score 0 Exchange Code ENOB Par Value ( $ ) n.a.
52 Weeks Volatility (%) 61.85 Free Float (%) 29.8
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 04 Feb 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 10 Dec 2018.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference ENOCHIAN BIOSCIENCES INC NASDAQ 183.821 - - 1.1351 -
Industry Biotechnology NASDAQ 2,874.069 106.306 106.381 6.6746 0.614
Local Peer AMGEN INC NASDAQ 143,265.040 19.723 20.221 15.3488 2.583
Local Peer GILEAD SCIENCES INC NASDAQ 83,403.540 678.051 277.663 4.3980 4.090
Local Peer MODERNA INC NASDAQ 65,165.311 - - 25.4414 -
Local Peer VERTEX PHARMACEUTICAL NASDAQ 55,354.047 20.413 20.041 6.1640 -
Local Peer ILLUMINA INC NASDAQ 55,239.100 84.206 87.681 11.2229 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 51,388.811 14.627 14.627 4.6610 -
Local Peer BIONTECH SE SPON ADS EACH REP 1 ORD SHS NASDAQ 41,244.541 2,380.733 2,380.592 24.5719 -
Local Peer BIOGEN INC NASDAQ 40,886.221 10.220 13.576 3.8275 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 37,553.338 62.236 55.055 3.0244 -
Local Peer BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS NASDAQ 28,005.546 - - 7.2380 -
Local Peer SEAGEN INC NASDAQ 24,513.913 39.946 37.106 7.1581 -
Local Peer 10X GENOMICS INC NASDAQ 20,092.589 - - 27.1861 -
Other Local Peers EXACT SCIENCES CORP (NASDAQ), INCYTE CORPORATION (NASDAQ), BIO-TECHNE CORP (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), NOVAVAX INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ABCELLERA BIOLOGICS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), EXELIXIS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), RECURSION PHARMACEUTICALS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), OLINK HLDG AB SPON ADS EACH REP 1 ORD SHS (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), SANA BIOTECHNOLOGY INC (NASDAQ), ALKERMES PLC (NASDAQ), ARVINAS INC (NASDAQ), INSMED INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), VERACYTE INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), ORGANOGENESIS HOLDINGS INC (NASDAQ), INSTIL BIO INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), SEER INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), OCUGEN INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), XENCOR INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), MACROGENICS INC (NASDAQ), FIBROGEN INC (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), CYTOKINETICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), KURA ONCOLOGY INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), IMMUNOCORE HLDGS PLC SPON ADS EACH REP ONE ORD SHS (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), BIONANO GENOMICS INC (NASDAQ), IMMUNOVANT INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), BIOATLA INC (NASDAQ), ALLOVIR INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), SHATTUCK LABS INC (NASDAQ), ALECTOR INC (NASDAQ), PRECIGEN INC (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), EDGEWISE THERAPEUTICS INC (NASDAQ), UNIQURE N.V. (NASDAQ), REGENXBIO INC (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), AFFIMED N V (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), MIMEDX GROUP INC (NASDAQ), OMEROS CORP (NASDAQ), PROTHENA CORP PLC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), HUMANIGEN INC (NASDAQ), CORTEXYME INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), VAXART INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), RADIUS HEALTH INC (NASDAQ), PASSAGE BIO INC (NASDAQ), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), PERSONALIS INC (NASDAQ), VOR BIOPHARMA INC (NASDAQ), NKARTA INC (NASDAQ), CURIS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), VANDA PHARMACE INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), VAXCYTE INC (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), MERUS B V (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), EPIZYME INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), AKOYA BIOSCIENCES INC (NASDAQ), IKENA ONCOLOGY INC (NASDAQ), IMMATICS N V (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), CHIMERIX INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), ATHIRA PHARMA INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), COMPUGEN (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), ARDELYX INC (NASDAQ), KADMON HLDGS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), INHIBRX INC (NASDAQ), IVERIC BIO INC (NASDAQ), AGENUS INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), ALTIMMUNE INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), VERASTEM INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), XBIOTECH INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), SESEN BIO INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), ADICET BIO INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), AKOUOS INC (NASDAQ), TERNS PHARMACEUTICALS INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), GERON CORP (NASDAQ), UROGEN PHARMA LTD (NASDAQ), LANDOS BIOPHARMA INC (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), XOMA CORP (NASDAQ), ATRECA INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), VIRACTA THERAPEUTICS INC (NASDAQ), ONCORUS INC (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), AVROBIO INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), SENSEI BIOTHERAPEUTICS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), CUE BIOPHARMA INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), ATHERSYS INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), PORTAGE BIOTECH INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), RAIN THERAPEUTICS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), LAVA THERAPEUTICS NV (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), KAMADA LTD (NASDAQ), TREVENA INC (NASDAQ), IMMUNOME INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), CHEMOMAB THERAPEUTICS LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), NEXTCURE INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), BIOVIE INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), CABALETTA BIO INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), MEDICINOVA INC (NASDAQ), MARKER THERAPEUTICS INC (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), DECIBEL THERAPEUTICS INC (NASDAQ), SAVARA INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), IMV INC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), EQUILLIUM INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), EVOGENE LTD (NASDAQ), IMMUNOPRECISE ANTIBODIES LTD (NASDAQ), INMUNE BIO INC (NASDAQ), SYNLOGIC INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), CHIASMA INC (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), CONTRAFECT CORP (NASDAQ), INFLARX N V (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), EVAXION BIOTECH AS SPON ADS EACH REP 1 ORD SHS (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), OTONOMY INC (NASDAQ), GAIN THERAPEUTICS INC (NASDAQ), VIRIDIAN THERAPEUTICS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), GLYCOMIMETICS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), LONGEVERON INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), ORGENESIS INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), ARAVIVE INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), AZIYO BIOLOGICS INC (NASDAQ), METACRINE INC (NASDAQ), PRECIPIO INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), CELYAD ONCOLOGY SPON ADS EACH REPR 1 ORD SHS (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), COHBAR INC (NASDAQ), RECRO PHARMA INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), VACCINEX INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), KIROMIC BIOPHARMA INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), ATYR PHARMA INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), ADVAXIS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), BIOCARDIA INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), SOLIGENIX INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), CYCLO THERAPEUTICS INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), APPLIED DNA SCIENCES INC (NASDAQ), PALISADE BIO INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), GEOVAX LABS INC (NASDAQ), HISTOGEN INC (NASDAQ), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), INMED PHARMACEUTICALS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), BRIACELL THERAPEUTICS CORP (NASDAQ), SENESTECH INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ)
Global Peer AMGEN-T HKEx 1,011,789.594 17.959 18.421 13.9429 2.837
Global Peer CSL LTD ASX 126,018.177 40.180 33.112 11.9253 1.060
Global Peer WUXI BIO HKEx 442,929.489 233.390 233.392 18.1663 -
Global Peer BEIGENE HKEx 220,516.296 - - 7.3502 -
Global Peer SINO BIOPHARM HKEx 148,557.864 47.708 47.709 7.4820 0.927
Global Peer ZAI LAB-SB HKEx 113,148.216 - - 12.4297 -
Global Peer JOINN HKEx 37,616.981 106.269 83.326 - 0.237
Global Peer GENSCRIPT BIO HKEx 35,233.938 - - 5.0394 -
Global Peer Lonza SGX 5,940.891 4.560 4.560 0.5844 5.624
Global Peer KINTOR PHARMA-B HKEx 23,215.558 - - 12.9852 -
Other Global Peers EMERGENT BIOSOLUTIONS INC (NYSE), ARCUS BIOSCIENCES INC (NYSE), NUVATION BIO INC (NYSE), 3SBIO (HKEx), JACOBIO-B (HKEx), MYOVANT SCIENCES LTD (NYSE), ALPHAMAB-B (HKEx), VIVA BIOTECH (HKEx), HAOHAI BIOTEC (HKEx), POLYNOVO LIMITED (ASX), JW THERAP-B (HKEx), FRONTAGE (HKEx), ASCENTAGE-B (HKEx), JHBP-B (HKEx), MESOBLAST LTD (ASX), TELIX PHARMACEUTIC (ASX), IMUGENE LIMITED (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), ANTEOTECH LIMITED (ASX), DPHARMA (Bursa), ASCLETIS-B (HKEx), SINOMAB BIO-B (HKEx), 22ND CENTURY GROUP INC (NYSE American), LINEAGE CELL THERAPEUTICS INC (NYSE American), ESSEX BIO-TECH (HKEx), OPTHEA LIMITED (ASX), LEE'S PHARM (HKEx), SQZ BIOTECHNOLOGIES CO (NYSE), NEXT SCIENCE LTD (ASX), NANOVIRICIDES INC (NYSE American), IMMUTEP LTD (ASX), CEL-SCI CORP (NYSE American), BIONOMICS LTD (ASX), BIOMX INC (NYSE American), ENZO BIOCHEM INC (NYSE), KAZIA THERAPEUTICS LIMITED (ASX), IBIO INC (NYSE American), NEUREN PHARMACEUTICALS LTD (ASX), ARMATA PHARMACEUTICALS INC (NYSE American), AIM IMMUNOTECH INC (NYSE American), UNI-BIO GROUP (HKEx), PALATIN TECHNOLOGIES INC (NYSE American), LEAF RESOURCES LTD (ASX), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), ACTINOGEN MEDICAL LTD (ASX), GENETIC TECHNOLOGIES (ASX), CYNATA THERAPEUTICS LTD (ASX), CHIMERIC THERAPEUTICS LTD (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), REGENT PACIFIC (HKEx), ALTERITY THERAPEUTICS LIMITED (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), PRESCIENT THERAPEUTICS LIMITED (ASX), CT ENTERPRISE (HKEx), INVEX THERAPEUTICS LTD NPV (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), PATRYS LIMITED (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), ORAGENICS INC (NYSE American), MEMPHASYS LTD (ASX), Suntar Eco-City (SGX), BIOTRON (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), REGENEUS LTD (ASX), ADALTA LTD (ASX), RHINOMED LIMITED (ASX), BIOSINO BIO-TEC (HKEx), CONSTELLATION TECHNOLOGIES LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), NANOLLOSE LTD (ASX), CRYOSITE (ASX), HOLISTA COLLTECH LIMITED (ASX), ANATARA LIFESCIENCES LTD (ASX), HAO WEN HLDGS (HKEx), LIVING CELL TECHNOLOGIES (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.420
+12.24 %
10 Days -+0.320
+9.07 %
20 Days -+0.780
+25.41 %
Medium Term Return 3 Months -+0.150
+4.05 %
6 Months -+0.790
+25.82 %
1 Year -+0.150
+4.05 %
Long Term Return 2 Years --1.840
-32.34 %
Annualised Return Annualised --
-17.74 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 2.600 - 13.430 Change From 1 Year Low +1.250 % Change From 1 Year Low (%) +48.08
Change From 1 Year High -9.580 % Change From 1 Year High (%) -71.33
2 Years Range 1.950 - 13.430 Change From 2 Years Low +1.900 % Change From 2 Years Low (%) +97.44
Change From 2 Years High -9.580 % Change From 2 Years High (%) -71.33
5 Years Range 1.950 - 13.430 Change From 5 Years Low +1.900 % Change From 5 Years Low (%) +97.44
Change From 5 Years High -9.580 % Change From 5 Years High (%) -71.33
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Enochian Biosciences, Inc. engages in the development of genetically modified cellular and immune-therapy technologies for treatment of infectious diseases and cancer. Its pipeline consists of ENOB-HV-01, ENOB- HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21. The company was founded by Rene Sindlev on January 18, 2011 and is headquartered in Los Angeles, CA.

Historical Price Data

Date Open High Low Close Volume VWAP
05 May 2021 3.690 3.935 3.620 3.850 242,083 -
04 May 2021 3.830 3.980 3.500 3.530 219,964 -
03 May 2021 3.450 3.810 3.450 3.760 254,019 -
30 Apr 2021 3.390 3.530 3.340 3.380 48,458 -
29 Apr 2021 3.450 3.480 3.330 3.430 51,546 -
28 Apr 2021 3.480 3.550 3.310 3.420 173,445 -
27 Apr 2021 3.580 3.580 3.480 3.510 36,637 -
26 Apr 2021 3.570 3.684 3.500 3.570 72,584 -
23 Apr 2021 3.500 3.565 3.420 3.520 72,065 -
22 Apr 2021 3.430 3.630 3.430 3.530 213,354 -
21 Apr 2021 3.390 3.700 3.370 3.460 229,119 -
20 Apr 2021 3.120 3.380 3.080 3.340 199,859 -
19 Apr 2021 3.140 3.240 3.000 3.070 150,309 -
16 Apr 2021 3.210 3.210 2.960 3.110 211,017 -
15 Apr 2021 3.100 3.290 2.981 3.210 177,759 -
14 Apr 2021 2.980 3.170 2.980 3.040 105,186 -
13 Apr 2021 3.085 3.085 2.860 2.970 54,865 -
12 Apr 2021 3.130 3.154 2.920 2.940 52,436 -
09 Apr 2021 3.050